Publications

White PaperOpinion ArticleConsumer-ledPhysiucian-ledPharmaceutical DevelopmentDrug Testing in SportRegulation & Governance

Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs Min, K. L., Ryu, J. Y. & Chang, M. J.. Basic Clin Pharmacol Toxicol, doi:10.1111/bcpt.13269 (2019).

Beyond dried blood spot: Current microsampling techniques in the context of biomedical applications Nys, G., Kok, M. G. M., Servais, A.-C. & Fillet, M.. TrAC Trends in Analytical Chemistry 97, 326-332, doi:10.1016/j.trac.2017.10.002 (2017).

Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring Antunes, M. V., Charao, M. F. & Linden, R.. Clin Biochem 49, 1035-1046, doi:10.1016/j.clinbiochem.2016.05.004 (2016).

Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children Martial, L. C. et al.. PLoS ONE 11, doi:10.1371/journal.pone.0167433 (2016).

Therapeutic drug monitoring by dried blood spot: progress to date and future directions Wilhelm, A. J., den Burger, J. C. & Swart, E. L.. Clin Pharmacokinet 53, 961-973, doi:10.1007/s40262-014-0177-7 (2014).

Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring Antunes, M. V., Charao, M. F. & Linden, R.. Clin Biochem 49, 1035-1046, doi:10.1016/j.clinbiochem.2016.05.004 (2016).

Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs Min, K. L., Ryu, J. Y. & Chang, M. J.. Basic Clin Pharmacol Toxicol, doi:10.1111/bcpt.13269 (2019).

Beyond dried blood spot: Current microsampling techniques in the context of biomedical applications Nys, G., Kok, M. G. M., Servais, A.-C. & Fillet, M.. TrAC Trends in Analytical Chemistry 97, 326-332, doi:10.1016/j.trac.2017.10.002 (2017).

Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring Antunes, M. V., Charao, M. F. & Linden, R.. Clin Biochem 49, 1035-1046, doi:10.1016/j.clinbiochem.2016.05.004 (2016).

Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children Martial, L. C. et al.. PLoS ONE 11, doi:10.1371/journal.pone.0167433 (2016).

Therapeutic drug monitoring by dried blood spot: progress to date and future directions Wilhelm, A. J., den Burger, J. C. & Swart, E. L.. Clin Pharmacokinet 53, 961-973, doi:10.1007/s40262-014-0177-7 (2014).

Dried blood spots, pharmacokinetic studies and better medicines for children Pandya, H. C., Spooner, N. & Mulla, H.. Bioanalysis 3, 779-786, doi:10.4155/BIO.11.19 (2011).

Land O’Lakes Workshop on Microsampling: Enabling Broader Adoption. Wickremsinhe, E. R. et al. AAPS J 22, 135, doi:10.1208/s12248-020-00524-2 (2020).

The development of patient-centric sampling as an enabling technology for clinical trials. Bateman K. Bioanalysis, doi:10.4155/bio-2020-0075 (2020).

Giving patients choices: AstraZeneca’s evolving approach to patient-centric sampling. Bailey, C., et al. Bioanalysis 12, 957-970, doi:10.4155/bio-2020-0105 (2020).

Microsampling: considerations for its use in pharmaceutical drug discovery and development Spooner, N. et al.. Bioanalysis 11, 1015-1038, doi:10.4155/bio-2019-0041 (2019).

Dried blood spots: concepts, present status, and future perspectives in bioanalysis Sharma, A., Jaiswal, S., Shukla, M. & Lal, J.. Drug Testing and Analysis 6, 399-414, doi:10.1002/dta.1646 (2014).